Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (210)	1/24/1997 5:07:00 PM
From: Peter Church	of 6136

Richard.... One thing that I don't understand about Agouron's strategy: why didn't they concentrate on the 2 PI model in their clinical trails? They only have 12 weeks of data now. Will they have to go through another 6 months to prove the efficacy of the treatment? Also, could you comment on the political workings of the drug world. Do drugs get market share based on a drug's scientific statistics alone or more based on the drug company's pull with the AMA or marketing strength? Does Agouron have what it takes to pull off a coup in the US market? Thanks for you comments....Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next